BIOMAT Database Logo BIOMAT Database Logo

[The programmed therapy of acute lymphoblastic leukemia in adults]. 1992

V G Isaev, and V G Savchenko, and R A Kucher, and E M Abakumov, and E N Parovichnikova

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

V G Isaev, and V G Savchenko, and R A Kucher, and E M Abakumov, and E N Parovichnikova
Therapy of acute lymphoblastic leukemia in adults.
January 1992, Leukemia,
V G Isaev, and V G Savchenko, and R A Kucher, and E M Abakumov, and E N Parovichnikova
Therapy for acute myeloid leukemia and acute lymphoblastic leukemia in adults.
February 1991, Current opinion in oncology,
V G Isaev, and V G Savchenko, and R A Kucher, and E M Abakumov, and E N Parovichnikova
Therapy Options in Treating Acute Lymphoblastic Leukemia in Adults.
July 2019, Oncology (Williston Park, N.Y.),
V G Isaev, and V G Savchenko, and R A Kucher, and E M Abakumov, and E N Parovichnikova
Induction therapy for adults with acute lymphoblastic leukemia.
November 2006, Current oncology reports,
V G Isaev, and V G Savchenko, and R A Kucher, and E M Abakumov, and E N Parovichnikova
Acute lymphoblastic leukemia in adults.
April 2000, Current treatment options in oncology,
V G Isaev, and V G Savchenko, and R A Kucher, and E M Abakumov, and E N Parovichnikova
Acute lymphoblastic leukemia in adults.
June 1985, Seminars in oncology,
V G Isaev, and V G Savchenko, and R A Kucher, and E M Abakumov, and E N Parovichnikova
Acute lymphoblastic leukemia in adults.
June 2011, Pediatric reports,
V G Isaev, and V G Savchenko, and R A Kucher, and E M Abakumov, and E N Parovichnikova
Acute lymphoblastic leukemia in adults.
October 1984, Annals of internal medicine,
V G Isaev, and V G Savchenko, and R A Kucher, and E M Abakumov, and E N Parovichnikova
Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults.
July 1984, Blood,
V G Isaev, and V G Savchenko, and R A Kucher, and E M Abakumov, and E N Parovichnikova
Treatment of acute lymphoblastic leukemia in adults.
January 1985, Hematological oncology,
Copied contents to your clipboard!